Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine

Recruiting now · Not applicable

Conditions studied: Tobacco-flavored EC, Sweet-Cooling EC, Sweet Non-cooling EC

In brief

This project aims to investigate the impact of e-cigarette flavors and usage patterns on achieving harm-reduction milestones in a sample of cigarette smokers with opioid use disorder who are taking buprenorphine

Key facts

Study ID

NCT07202039

Run by

Prisma Health-Upstate

People needed

90

Starts

2026-04-29

Expected to finish

2029-06-29

Last updated by the study team

2026-05-12

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥21 years
• Smoke ≥5 CPD for ≥1 year
• Daily CC smoker
• Willing to switch to EC
• Exhaled CO ≥6 ppm
• Diagnosed with OUD
• Stable on bupropion treatment
• In good physical and mental health
• Able to use a smartphone
• Willing to participate in all study components
• Able to provide informed consent Exclusion Criteria
• Interested in quitting CC (contemplation stage of change)
• Use of EC on ≥4 of the past 30 days
• Use of other tobacco products (e.g., cigars, smokeless tobacco) on ≥9 days of the past 30 days
• Use of nicotine replacement therapy, smoking cessation medication, or a cessation attempt in the past 30 days
• Hypertension
• Medical condition that would contraindicate participation
• Meet DSM-V criteria for major depressive episode, psychotic episode, or manic episode
• Current suicidal ideation or suicide attempt in the past year
• Psychiatric hospitalization in the past year
• Contemplating pregnancy, currently pregnant, or breastfeeding
• Unable to speak and/or read English

Where it is running

• Addiction Medicine Center — Greenville, South Carolina, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.